Contribution of gut microbiota to drug-induced liver injury

被引:15
|
作者
Chu, Hui-Kuan [1 ]
Ai, Yan [1 ]
Cheng, Zi-Lu [1 ]
Yang, Ling [1 ]
Hou, Xiao-Hua [1 ]
机构
[1] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Div Gastroenterol, Wuhan 430022, Peoples R China
基金
中国国家自然科学基金;
关键词
Gut microbiota; Lipopolysaccharide; Probiotics; Fecal microbiota transplantation; Drug -induced Liver injury; SIGNAL-TRANSDUCTION PATHWAYS; AKKERMANSIA-MUCINIPHILA; INTESTINAL MICROBIOME; RECEPTOR; 4; ACETAMINOPHEN; MICE; PROTECTS; HEPATOTOXICITY; INFLAMMATION; ENDOTOXEMIA;
D O I
10.1016/j.hbpd.2023.06.008
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Drug-induced liver injury (DILI) is caused by various drugs with complex pathogenesis, and diverse clinical and pathological phenotypes. Drugs damage the liver directly through drug hepatotoxicity, or indirectly through drug-mediated oxidative stress, immune injury and inflammatory insult, which eventually lead to hepatocyte necrosis. Recent studies have found that the composition, relative content and distribution of gut microbiota in patients and animal models of DILI have changed significantly. It has been confirmed that gut microbial dysbiosis brings about intestinal barrier destruction and microorganisms translocation, and the alteration of microbial metabolites may cause or aggravate DILI. In addition, antibiotics, probiotics, and fecal microbiota transplantation are all emerging as prospective therapeutic methods for DILI by regulating the gut microbiota. In this review, we discussed how the altered gut microbiota participates in DILI.(c) 2023 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:458 / 465
页数:8
相关论文
共 50 条
  • [31] Drug-Induced Liver Injury
    Hamilton, Leslie A.
    Collins-Yoder, Angela
    Collins, Rachel E.
    AACN ADVANCED CRITICAL CARE, 2016, 27 (04) : 430 - 440
  • [32] Immune-Mediated Drug-Induced Liver Injury: Immunogenetics and Experimental Models
    Gerussi, Alessio
    Natalini, Ambra
    Antonangeli, Fabrizio
    Mancuso, Clara
    Agostinetto, Elisa
    Barisani, Donatella
    Di Rosa, Francesca
    Andrade, Raul
    Invernizzi, Pietro
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (09)
  • [33] Gut microbiota exaggerates triclosan-induced liver injury via gut-liver axis
    Zhang, Peng
    Zheng, Liyang
    Duan, Yitao
    Gao, Yuting
    Gao, Huihui
    Mao, Daqing
    Luo, Yi
    JOURNAL OF HAZARDOUS MATERIALS, 2022, 421
  • [34] An Update on Treatment of Drug-Induced Liver Injury
    Giordano, Christin
    Rivas, John
    Zervos, Xaralambos
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2014, 2 (02) : 74 - 79
  • [35] Drug-Induced Liver Injury: Review Article
    Wissam Bleibel
    Stephen Kim
    Karl D’Silva
    Eric R. Lemmer
    Digestive Diseases and Sciences, 2007, 52 : 2463 - 2471
  • [36] Drug-induced liver injury: Review article
    Bleibel, Wissam
    Kim, Stephen
    D'Silva, Karl
    Lemmer, Eric R.
    DIGESTIVE DISEASES AND SCIENCES, 2007, 52 (10) : 2463 - 2471
  • [37] Zebrafish as model organisms for studying drug-induced liver injury
    Vliegenthart, A. D. Bastiaan
    Tucker, Carl S.
    Del Pozo, Jorge
    Dear, James W.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 78 (06) : 1217 - 1227
  • [38] Drug-induced liver injury due to antibiotics
    Bjornsson, Einar S.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2017, 52 (6-7) : 617 - 623
  • [39] A review of drug-induced liver injury databases
    Guangwen Luo
    Yiting Shen
    Lizhu Yang
    Aiping Lu
    Zheng Xiang
    Archives of Toxicology, 2017, 91 : 3039 - 3049
  • [40] Mitochondrial Dynamics in Drug-Induced Liver Injury
    Ramachandran, Anup
    Umbaugh, David S.
    Jaeschke, Hartmut
    LIVERS, 2021, 1 (03): : 102 - 115